3D Encapsulation and tethering of functionally engineered extracellular vesicles to hydrogels.

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Stem Cell Biology

Background:

• Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) show therapeutic promise but lack spatial and temporal control in vivo.
• Current stem cell therapies face challenges with targeted delivery and maintaining therapeutic efficacy.
• Engineering EVs offers potential for regenerative medicine, but controlled delivery is crucial.

Purpose of the Study:

• To develop a 3D hydrogel system for encapsulating and prolonging the delivery of MSC-derived EVs.
• To leverage MSC EV interactions with extracellular matrix (ECM) proteins for enhanced tethering and retention.
• To evaluate the in vivo efficacy of tethered EVs in a bone regeneration model.

Main Methods:

• Utilized osteoinductive functionally engineered EVs (FEEs) derived from MSCs.
• Incorporated ECM-mimetic peptides (RGD from fibronectin) into photocrosslinkable alginate hydrogels.
• Assessed in vitro FEE retention and functionality over 7 days.
• Evaluated bone regeneration in a murine calvarial defect model using alginate-RGD hydrogels with FEEs.

Main Results:

• Alginate-RGD hydrogels successfully encapsulated, tethered, and retained FEEs for 7 days in vitro, preserving their structural integrity and osteoinductive function.
• In vivo, alginate-RGD hydrogels with FEEs promoted bone regeneration, increasing it 4-fold compared to controls without FEEs.
• The tethering peptide (RGD) significantly improved bone regeneration by 2-fold compared to hydrogels without the peptide.

Conclusions:

• Tethering EVs to biomaterials via ECM interactions is an effective strategy for promoting bone repair.
• Prolonged in vivo delivery of functional EVs is critical for enhanced therapeutic outcomes.
• This tunable hydrogel platform offers a promising approach for controlled EV delivery in regenerative medicine applications.